title: Transgenic mouse model of AA amyloidosis.
abstract: AA amyloidosis can be induced in mice experimentally through injection of certain chemical or biological compounds. However, the usefulness of this approach is limited by its dependence on exogenous inflammatory agents that stimulate cytokines to increase the synthesis of precursor serum amyloid A (SAA) protein and the transitory nature of the pathological fibrillar deposits. We now report that transgenic mice carrying the human interleukin 6 gene under the control of the metallothionein-I promoter had markedly increased concentrations of SAA and developed amyloid in the spleen, liver, and kidneys by 3 months of age. At the time of death about 6 months later, organs obtained from these animals had extensive amyloid deposits. This disease process was apparent radiographically using small-animal computer axial tomography and magnetic resonance imaging equipment. The AA nature of the amyloid was evidenced immunohistochemically and was unequivocally established by sequence analysis of protein extracted from the fibrils. The availability of this unique in vivo experimental model of AA amyloidosis provides the means to assess the therapeutic efficacy of agents designed to reduce or prevent the fibrillar deposits found in AA and other types of amyloid-associated disease.
authors.affiliation: Department of Medicine, University of Tennessee Medical Center/Graduate School of Medicine, Knoxville, Tennessee 37920, USA. asolomon@MC.UTMCK.edu
authors.forename: A
authors.initials: A
authors.lastname: Solomon
authors.forename: D T
authors.initials: DT
authors.lastname: Weiss
authors.forename: M
authors.initials: M
authors.lastname: Schell
authors.forename: R
authors.initials: R
authors.lastname: Hrncic
authors.forename: C L
authors.initials: CL
authors.lastname: Murphy
authors.forename: J
authors.initials: J
authors.lastname: Wall
authors.forename: M D
authors.initials: MD
authors.lastname: McGavin
authors.forename: H J
authors.initials: HJ
authors.lastname: Pan
authors.forename: G W
authors.initials: GW
authors.lastname: Kabalka
authors.forename: M J
authors.initials: MJ
authors.lastname: Paulus
mesh_terms: D000595:Amino Acid Sequence; D000686:Amyloidosis / Q000097:blood / Q000235:genetics* / Q000473:pathology; D000818:Animals; D001842:Bone and Bones / Q000473:pathology; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics*; D007668:Kidney / Q000378:metabolism / Q000473:pathology; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008668:Metallothionein / Q000235:genetics*; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008822:Mice, Transgenic / Q000235:genetics*; D008969:Molecular Sequence Data; D000685:Serum Amyloid A Protein / Q000235:genetics / Q000378:metabolism / Q000648:ultrastructure; D013154:Spleen / Q000378:metabolism / Q000473:pathology; D014057:Tomography, X-Ray Computed
chemical_list: D015850:Interleukin-6; D000685:Serum Amyloid A Protein; D008668:Metallothionein